Brief: Qualigen Therapeutics Inc Receives Nasdaq Notice Regarding Delayed Form 10-K Filing
21/04/2023 23:31
April 21 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. RECEIVES NASDAQ NOTICE
REGARDING
DELAYED FORM 10-K FILING
* QUALIGEN THERAPEUTICS INC - ON APRIL 20 RECEIVED LETTER
FROM
NASDAQ RELATING TO CO'S FAILURE TO TIMELY FILE ANNUAL REPORT ON
FORM 10-K FOR 2022
Source text for Eikon: ID:nGNX3WWmfN
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise